Cancer drug gets stronger label warning
January 13, 2012 —
Seattle Genetics cancer drug price may top $100,000
August 22, 2011 — WASHINGTON (Reuters) - The price of Seattle Genetics Inc's blood cancer drug Adcetris could top $100,000 for a course of treatment, becoming the latest cancer medicine to come at a high cost.
FDA approves Seattle Genetics cancer drug
August 19, 2011 — WASHINGTON (Reuters) - U.S. drug regulators on Friday approved a blood cancer medicine by Seattle Genetics Inc, making it the first drug for Hodgkin's lymphoma approved since 1977.
Select news items provided by Reuters Health